Apellis Pharmaceuticals (APLS) PT Lowered to $32 at Wedbush
Tweet
Share
E-mailGet Alerts APLS Hot Sheet
Price: $41.03 --0%
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 12
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 12
Join SI Premium – FREE
Wedbush analyst Laura Chico lowered the price target on Apellis Pharmaceuticals (NASDAQ: APLS) to $32.00 (from $40.00) while maintaining a Neutral rating.
You May Also Be Interested In
- American Silver Corp. (USAS) PT Lowered to $9.25 at H.C. Wainwright
- BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $59 at H.C. Wainwright
- AGC Inc (5201:JP) (ASGLY) PT Lowered to JPY8,030 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
